Why Better Therapeutics Are Trading Higher By 51%; Here Are 20 Stocks Moving Premarket

Gainers

• CytoMed Therapeutics Limited GDTC shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on Monday.
• Better Therapeutics, Inc. BTTX shares gained 51.1% to $1.36 in pre-market trading after the FDA approved the company's AspyreRx prescription-only digital therapeutic treatment to provide cognitive behavioral therapy to adult patients with type 2 diabetes.
• Crown ElectroKinetics Corp. CRKN shares rose 42.2% to $0.1450 in pre-market trading after declining around 14% on Monday.
• Trinity Place Holdings Inc. TPHS gained 24.1% to $0.6790 in pre-market trading after declining around 15% on Monday.
• TC Biopharm (Holdings) Plc TCBP shares rose 20.8% to $0.54 in pre-market trading.
• NanoViricides, Inc. NNVC rose 19.9% to $1.69 in pre-market trading. NanoViricides reported effectiveness of antiviral clinical drug candidate NV-387 in an animal model of lethal lung infection with respiratory syncytial virus.
• Acumen Pharmaceuticals, Inc. ABOS shares climbed 18.2% to $5.86 in pre-market trading. Acumen Pharmaceuticals recently announced it will present topline results from a Phase 1 trial of its candidate ACI193 at the Alzheimer's Association International Conference in July.
• CN Energy Group. Inc. CNEY rose 15.6% to $0.2110 in pre-market trading after falling around 6% on Monday.
• T2 Biosystems, Inc. TTOO gained 14.5% to $0.1811 in pre-market trading after jumping around 37% on Monday.
• Caravelle International Group CACO shares gained 12.6% to $0.6190 in pre-market trading.

Losers

• DSS, Inc. DSS fell 17.1% to $0.3002 in pre-market trading. DSS Wealth, Inc., a wholly owned subsidiary of DSS, Inc, named Daniel Lew as Chief Investment Officer and Portfolio Manager.
• Viridian Therapeutics, Inc. VRDN fell 14.4% to $20.99 in pre-market trading after announcing data from ongoing Phase 1/2 trial evaluating VRDN-001 in patients with chronic thyroid eye disease.
• Iovance Biotherapeutics, Inc. IOVA fell 12.5% to $7.69 in pre-market trading as the company priced its underwritten public offering of 20,000,000 shares at $7.50 per share.
• Jupiter Wellness, Inc. JUPW fell 11.9% to $0.4845 in pre-market trading. Jupiter Wellness shares jumped over 50% on Monday after the company announced it has executed an Asset Purchase Agreement with GBB Drink Lab to acquire all operating assets including the "Safety Shot" rapid alcohol detox drink.
• REE Automotive Ltd. REE shares dropped 10.5% to $0.34 in pre-market trading. REE Automotive recently named Carlton Rose, former global president of fleet maintenance and engineering at UPS, to the company’s board of directors.
• Tattooed Chef, Inc. TTCF fell 10.1% to $0.1889 in pre-market trading after declining 19% on Monday. Tattooed Chef recently announced it intends to file for voluntary Chapter 11 Bankruptcy protection.
• Journey Medical Corporation DERM shares fell 9.2% to $2.58 in pre-market trading after climbing around 21% on Monday.
• EZFill Holdings Inc. EZFL fell 9.1% to $2.00 in pre-market. EzFill achieved another quarterly record for gallons delivered in the second quarter.
• urban-gro, Inc. UGRO shares fell 8.1% to $1.83 in pre-market trading after rising around 5% on Monday.
• Ryvyl Inc. RVYL fell 7.8% to $1.07 in pre-market trading after gaining over 5% on Monday.

Now Read This: Market Volatility Increases Ahead Of Inflation Reports; S&P 500 Settles Higher